0

Breast Cancer Liquid Biopsy Market Expected to Reach $357,051 Thousand by 2027

 
2022
Breast Cancer Liquid Biopsy Market

Report Code : A07618

quote growth of the breast cancer liquid biopsy market is attributed to rise in prevalence of breast cancer across the globe. Furthermore, rise in demand for reagent kits, increase in preference of noninvasive procedures, and rise in patient awareness toward breast cancer treatment are the other factors that contribute to the growth of the market. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Breast Cancer Liquid Biopsy Market by Product & Service, Circulating Biomarker, and Application: Opportunity Analysis and Industry Forecast, 2019–2027," the global breast cancer liquid biopsy market was valued at $87,641 thousand in 2019, and is projected to reach $357,051 thousand by 2027, registering a CAGR of 19.2% from 2019 to 2027.

Breast cancer liquid biopsy provides a real-time method for treatment of breast cancer. It is used for collection & analysis of a blood sample taken from patients. It analyses the presence of tumor cell-derived biomarkers such as circulating tumor cells, extracellular vesicles, and circulating tumor DNA. A breast cancer liquid biopsy is a simple, noninvasive, and cost-effective diagnostic tool for breast cancer. Breast cancer is known to be the second most common malignancy across the globe, therefore, liquid biopsy is a very significant tool for breast cancer diagnosis and determination.

The major factors that boosts growth of the breast cancer liquid biopsy market include rise in prevalence of breast cancer, surge in propensity for non-invasive procedures, increase in patient awareness toward breast cancer diagnosis and treatment, intensive R&D in the field of breast cancer, and inclination toward personalized medicine. In addition, technological advancements to detect breast cancer at early stage, rise in demand for better minimally invasive therapies for breast cancer treatment, easy accessibility and high adoption of polymerase chain reaction (PCR) and next-generation sequencing (NGS) among healthcare professionals, and increase in product approvals are also anticipated to drive growth of the market. However, limitations associ ated with liquid biopsy testing and lack of access and awareness regarding breast cancer liquid biopsy in underdeveloped countries are expected to hinder growth of the breast cancer liquid biopsy market.

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. This COVID-19 pandemic has affected breast cancer liquid biopsy reagent kits production and import & export of raw material and finished goods, owing to shutdowns in various COVID-19-affected countries. Temporary disruptions of inputs or production might stress some companies, particularly those with inadequate liquidity. Moreover, delayed shipments & production schedules create financial problems for companies with heavy debts. This, in turn, has limited the impact of COVID-19 on the market.

The global breast cancer liquid biopsy market is segmented into product & service, circulating biomarker, application, and region. Based on product & service, the market is categorized into reagent kits, instruments, and services. The reagent kits segment dominated the global market in 2019, and is anticipated to continue this trend during the forecast period. Key factors such as advent of novel liquid biopsy reagents that execute circulating biomarker analysis and target enrichment; increase in breast cancer liquid biopsy reagent kits approvals; and increase in funding for breast cancer liquid biopsy R&D are anticipated to drive the growth of the market. In addition, surge in demand for reagent kits, rise in number of breast cancer liquid biopsy test procedures, and increase in prevalence of breast cancer across the globe are other factors that contribute toward growth of the breast cancer liquid biopsy market.

On the basis of application, the breast cancer liquid biopsy market is classified into diagnostics, prognostics, and risk assessment. The diagnostics segment accounted for maximum market revenue in 2019, and is anticipated to maintain its dominant position during the forecast period, owing to rise in number of patients suffering from breast cancer, rise in trend of developing personalized therapeutics, technological advancements in liquid biopsy systems, and increase in patient awareness toward safe and non-invasive liquid biopsy testing procedures

Key Findings Of The Study 

  • By product & service, the reagent kits segment held largest market share in 2019, and is expected to remain dominant throughout the forecast period.
  • On the basis of circulating biomarker, the circulating tumor cell segment held largest market share in 2019, and is expected to remain dominant throughout the forecast period. 
  • According to application, the diagnostics segment exhibits fastest growth, and is expected to grow at a CAGR of 20.2% from 2019 to 2027.
  • Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 20.7% during the forecast period. 

North America accounted for the largest share of the global breast cancer liquid biopsy market in 2019, and is expected to remain dominant throughout the forecast period. This was attributed to increase in prevalence of breast cancer and higher number of R&D activities to develop novel breast cancer liquid biopsy reagent kits. Moreover, large number of target population with higher health awareness, availability of trained medical professionals, and rise in investments by leading market players and hospitals are other factors that fuel growth of the market. 

Asia-Pacific is expected to experience highest growth rate during the forecast period, majorly owing to growth in prevalence of breast cancer and surge in patient awareness toward the use of breast cancer liquid biopsy technique.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Breast Cancer Liquid Biopsy Market by Product & Service (Reagent Kits, Instruments, and Services), Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, and Circulating Tumor DNA), and Application (Diagnostics, Prognostics, and Risk Assessment): Global Opportunity Analysis and Industry Forecast, 2019–2027 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Nov 2024

Plush Toy Market

Download Sample

Buy Full Version
"Breast Cancer Liquid Biopsy Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers